We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR-Based POC Molecular Diagnostic System to Combat Infectious Diseases

By LabMedica International staff writers
Posted on 28 Jan 2025

Chlamydia, Gonorrhea, and Trichomoniasis are among the most common sexually transmitted infections (STIs) worldwide, with an estimated 129 million, 82 million, and 151 million cases respectively reported in 2020. More...

Detecting these infections accurately typically relies on PCR-based molecular diagnostics, which have traditionally been carried out in centralized laboratories that require significant infrastructure. This setup limits accessibility in low- and middle-income countries where medical resources are often scarce. Now, a point-of-care (POC) molecular diagnostic device integrates all processes into a single, compact instrument to provide a rapid, reliable solution for detecting STIs, enabling timely interventions in resource-constrained settings.

Kryptos Biotechnologies (Hayward, CA, USA) is advancing its proprietary PCR-based POC molecular diagnostic system, the KUICK System, designed to combat infectious diseases and enhance healthcare outcomes globally. Kryptos is collaborating with Osang Healthcare (Gyeonggi-do, Republic of Korea) for a research project that will focus on developing molecular diagnostic reagents for STIs. The aim of this collaboration is to create a multiplex STI diagnostic test capable of detecting Chlamydia, Gonorrhea, and Trichomoniasis in under 30 minutes from a single patient sample.

As part of this collaboration, Osang will develop real-time PCR reagents, while Kryptos will focus on optimizing the KUICK System, particularly its innovative cartridge with integrated sample preparation chemistries. The system’s performance is also being improved to ensure reliability in diverse healthcare settings. In developed countries, the device will allow smaller clinics to offer accurate, same-day results, thereby significantly improving patient care.

“Our proprietary photothermal heating technology enables the KUICK System to meet diverse market demands for speed, accuracy, cost-efficiency, and portability,” said Dr. Jun Ho Son, CTO of Kryptos Biotechnologies and principal investigator of the project. “We are committed to ensuring this product makes a meaningful impact on healthcare environments, particularly in low- and middle-income countries.”

Related Links:
Kryptos Biotechnologies 
Osang Healthcare


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.